Publications by authors named "Yoshiko Azuma"

Claim this Profile
C
Clinical efficacy of mogamulizumab for relapsed/refractory aggressive adult T-cell leukemia/lymphoma: A retrospective analysis.
Atsushi Satake, Akiko Konishi, Yoshiko Azuma, Yukie Tsubokura, Hideaki Yoshimura

Eur J Haematol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mycophenolic acid, the active form of mycophenolate mofetil, interferes with IRF7 nuclear translocation and type I IFN production by plasmacytoid dendritic cells.
Minoru Shigesaka, Tomoki Ito, Muneo Inaba, Kai Imai, Hideki Yamanaka, Yoshiko Azuma

Arthritis Res Ther· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunomodulatory drugs suppress Th1-inducing ability of dendritic cells but enhance Th2-mediated allergic responses.
Vien Phan, Tomoki Ito, Muneo Inaba, Yoshiko Azuma, Kayoko Kibata

Blood Adv· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of azacitidine in patients with transplant-ineligible myelodysplastic syndromes and acute myeloid leukemia with myelodysplasia-related changes in a Japanese clinical setting.
Aya Nakaya, Shinya Fujita, Atsushi Satake, Takahisa Nakanishi, Yoshiko Azuma

Oncol Lett· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of recombinant thrombomodulin on long-term prognosis after allogeneic hematopoietic stem cell transplantation.
Shosaku Nomura, Akiko Konishi, Yukie Tsubokura, Yoshiko Azuma, Masaaki Hotta

Transpl Immunol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trend of salvage treatment in diffuse large B cell lymphoma in the outpatient chemotherapy era.
Aya Nakaya, Shinya Fujita, Atsushi Satake, Takahisa Nakanishi, Yoshiko Azuma

Mol Clin Oncol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Statins can suppress DC-mediated Th2 responses through the repression of OX40-ligand and CCL17 expression.
Noriko Inagaki-Katashiba, Tomoki Ito, Muneo Inaba, Yoshiko Azuma, Akihiro Tanaka

Eur J Immunol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A variant of acute promyelocytic leukemia with t(4;17)(q12;q21) showed two different clinical symptoms.
Takahisa Nakanishi, Aya Nakaya, Yusuke Nishio, Shinya Fujita, Atsushi Satake, Yoshiko Azuma

Hematol Rep· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Successful treatment with brentuximab vedotin maintenance therapy after autologous stem cell transplantation in high-risk Hodgkin lymphoma].
Kazuyoshi Ishii, Yoshiko Azuma, Akiko Konishi, Yukie Tsubokura, Hideaki Yoshimura

Rinsho Ketsueki· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutrophil-to-lymphocyte ratio (NLR) fails to predict outcome of diffuse large B cell lymphoma.
Yoshiko Azuma, Aya Nakaya, Shinya Fujita, Atsushi Satake, Takahisa Nakanishi

Leuk Res Rep· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective analysis of adolescent and young adult with lymphoma at two cancer facilities in Japan.
Aya Nakaya, Shinya Fujita, Atsushi Satake, Takahisa Nakanishi, Yoshiko Azuma

Leuk Res Rep· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myodesopsia is a symptom of central nervous system blast crisis in chronic myeloid leukemia.
Kazuyoshi Ishii, Aya Nakaya, Shinya Fujita, Atsushi Satake, Yoshiko Azuma

Leuk Res Rep· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of eltrombopag in patients with aplastic anemia in real-world experience.
Akiko Konishi, Aya Nakaya, Shinya Fujita, Atsushi Satake, Takahisa Nakanishi, Yoshiko Azuma

Leuk Res Rep· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical significance of dasatinib-induced pleural effusion in patients with de chronic myeloid leukemia.
Aya Nakaya, Shinya Fujita, Atsushi Satake, Takahisa Nakanishi, Yoshiko Azuma

Hematol Rep· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined Use of Ninjin'yoeito Improves Subjective Fatigue Caused by Lenalidomide in Patients With Multiple Myeloma: A Retrospective Study.
Tomoki Ito, Akiko Konishi, Yukie Tsubokura, Yoshiko Azuma, Masaaki Hotta

Front Nutr· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secondary pure red cell aplasia in multiple myeloma treated with lenalidomide.
Tomoki Ito, Aya Nakaya, Shinya Fujita, Atsushi Satake, Takahisa Nakanishi, Yoshiko Azuma

Leuk Res Rep· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blastic Epstein-Barr virus associated post-transplant lymphoproliferative disorder after allogeneic stem cell transplantation for severe aplastic anemia.
Masaaki Hotta, Aya Nakaya, Shinya Fujita, Atsushi Satake, Takahisa Nakanishi, Yoshiko Azuma

Hematol Rep· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human T-cell Leukemia Virus Type I Associated with an Increased Risk of Primary Malignant Neoplasm.
Aya Nakaya, Shinya Fujita, Atsushi Satake, Takahisa Nakanishi, Yoshiko Azuma

Mediterr J Hematol Infect Dis· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tyrosine kinase inhibitor and rituximab-CHOP treatment for concurrent chronic myeloid leukemia and non-Hodgkin lymphoma: a case report.
Yuki Takeyasu, Atsushi Satake, Yoshiko Azuma, Yukie Tsubokura, Hideaki Yoshimura

Clin Case Rep· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dasatinib-induced hemorrhagic colitis complicated with cytomegalovirus infection.
Aya Nakaya, Yoshiko Azuma, Shinya Fujita, Atsushi Satake, Takahisa Nakanishi

Hematol Rep· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Realistic Lenalidomide Dose Adjustment Strategy for Transplant-Ineligible Elderly Patients with Relapsed/Refractory Multiple Myeloma: Japanese Real-World Experience.
Aya Nakaya, Shinya Fujita, Atsushi Satake, Takahisa Nakanishi, Yoshiko Azuma

Acta Haematol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transplant-Ineligible Symptomatic but Indolent Multiple Myeloma Shows Better Prognosis with Conventional Agents.
Aya Nakaya, Shinya Fujita, Atsushi Satake, Takahisa Nakanishi, Yoshiko Azuma

Case Rep Oncol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upfront high-dose chemotherapy combined with autologous stem cell transplantation: Potential survival benefit for patients with high-risk diffuse large B-cell lymphoma.
Aya Nakaya, Shinya Fujita, Atsushi Satake, Takahisa Nakanishi, Yoshiko Azuma

Oncol Lett· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of CRAB Symptoms in Survival of Patients with Symptomatic Myeloma in Novel Agent Era.
Aya Nakaya, Shinya Fujita, Atsushi Satake, Takahisa Nakanishi, Yoshiko Azuma

Hematol Rep· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delayed HBV reactivation in rituximab-containing chemotherapy: How long should we continue anti-virus prophylaxis or monitoring HBV-DNA?
Aya Nakaya, Shinya Fujita, Atsushi Satake, Takahisa Nakanishi, Yoshiko Azuma

Leuk Res· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis